These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17591940)

  • 1. A comparative study of five technologically diverse CFTR testing platforms.
    Johnson MA; Yoshitomi MJ; Richards CS
    J Mol Diagn; 2007 Jul; 9(3):401-7. PubMed ID: 17591940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The c.1364C>A (p.A455E) Mutation in the CFTR Pseudogene Results in an Incorrectly Assigned Carrier Status by a Commonly Used Screening Platform.
    Deeb KK; Metcalf JD; Sesock KM; Shen J; Wensel CA; Rippel LI; Smith M; Chapman MS; Zhang S
    J Mol Diagn; 2015 Jul; 17(4):360-5. PubMed ID: 25956447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosensor technology for real-time detection of the cystic fibrosis W1282X mutation in CFTR.
    Feriotto G; Ferlini A; Ravani A; Calzolari E; Mischiati C; Bianchi N; Gambari R
    Hum Mutat; 2001; 18(1):70-81. PubMed ID: 11438995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence-based oligonucleotide ligation assay for analysis of cystic fibrosis transmembrane conductance regulator gene mutations.
    Eggerding FA; Iovannisci DM; Brinson E; Grossman P; Winn-Deen ES
    Hum Mutat; 1995; 5(2):153-65. PubMed ID: 7538376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
    Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
    Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DHPLC screening of cystic fibrosis gene mutations.
    Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
    Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid screening for 31 mutations and polymorphisms in the cystic fibrosis transmembrane conductance regulator gene by Lminex xMAP suspension array.
    Dunbar SA; Jacobson JW
    Methods Mol Med; 2005; 114():147-71. PubMed ID: 16156102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
    Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a BeadXpress assay for a 151-mutation and variant CFTR screening panel after 11,000 samples: implications for practice.
    Stoerker J; Goodman TG; Walline HM; Sugalski J; Holland CA
    Diagn Mol Pathol; 2013 Sep; 22(3):144-8. PubMed ID: 23846440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended gene analysis can increase specificity of neonatal screening for cystic fibrosis.
    Mérelle ME; Scheffer H; De Jong D; Dankert-Roelse JE
    Acta Paediatr; 2006 Nov; 95(11):1424-8. PubMed ID: 17062471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray analysis in cystic fibrosis.
    Galvin P; Clarke LA; Harvey S; Amaral MD
    J Cyst Fibros; 2004 Aug; 3 Suppl 2():29-33. PubMed ID: 15463921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of CFTR mutations using ARMS and low-density microarrays.
    Eaker S; Johnson M; Jenkins J; Bauer M; Little S
    Biosens Bioelectron; 2005 Dec; 21(6):933-9. PubMed ID: 15890513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of cystic fibrosis mutation analysis using ABI 3130XL genetic analyzer.
    Huang CK; Pan Q
    Diagn Mol Pathol; 2007 Mar; 16(1):57-9. PubMed ID: 17471160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB; Comeau AM
    J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid, efficient, and sensitive assay for simultaneous detection of multiple cystic fibrosis mutations.
    Costes B; Fanen P; Goossens M; Ghanem N
    Hum Mutat; 1993; 2(3):185-91. PubMed ID: 7689902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-range (17.7 kb) allele-specific polymerase chain reaction method for direct haplotyping of R117H and IVS-8 mutations of the cystic fibrosis transmembrane regulator gene.
    Pont-Kingdon G; Jama M; Miller C; Millson A; Lyon E
    J Mol Diagn; 2004 Aug; 6(3):264-70. PubMed ID: 15269305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single tube multiplex PCR detection of 27 cystic fibrosis mutations and 4 polymorphisms using neonatal blood samples collected on Guthrie cards.
    Makowski GS; Nadeau FL; Hopfer SM
    Ann Clin Lab Sci; 2003; 33(3):243-50. PubMed ID: 12956437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One multiplex control for 29 cystic fibrosis mutations.
    Lebo RV; Bixler M; Galehouse D
    Genet Test; 2007; 11(3):256-68. PubMed ID: 17949287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Borderline sweat test: Utility and limits of genetic analysis for the diagnosis of cystic fibrosis.
    Seia M; Costantino L; Paracchini V; Porcaro L; Capasso P; Coviello D; Corbetta C; Torresani E; Magazzù D; Consalvo V; Monti A; Costantini D; Colombo C
    Clin Biochem; 2009 May; 42(7-8):611-6. PubMed ID: 19318035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.